KR940021733A - Method for preparing non-structural 5-1.2 protein of hepatitis C virus - Google Patents

Method for preparing non-structural 5-1.2 protein of hepatitis C virus Download PDF

Info

Publication number
KR940021733A
KR940021733A KR1019930004165A KR930004165A KR940021733A KR 940021733 A KR940021733 A KR 940021733A KR 1019930004165 A KR1019930004165 A KR 1019930004165A KR 930004165 A KR930004165 A KR 930004165A KR 940021733 A KR940021733 A KR 940021733A
Authority
KR
South Korea
Prior art keywords
protein
virus
structural
hepatitis
expression vector
Prior art date
Application number
KR1019930004165A
Other languages
Korean (ko)
Inventor
조중명
김천형
Original Assignee
최근선
주식회사 럭키
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 최근선, 주식회사 럭키 filed Critical 최근선
Priority to KR1019930004165A priority Critical patent/KR940021733A/en
Priority to KR1019930026611A priority patent/KR100285585B1/en
Publication of KR940021733A publication Critical patent/KR940021733A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/95—Fusion polypeptide containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24251—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

본 발명은 HCV의 비구조 5-1.2 단백질의 유전자를 유비퀴틴 유전자와 결합된 상태로 포함하여 그의 발현시 HCV의 비구조 5-1.2 단백질과 유비퀴틴의 융합단백질을 생산하는 발현벡터, 상기 발현벡터를 사용하여 HCV의 비구조 5-1.2 단백질을 대량 생산하는 방법 및 이에 의해 생산된 유비퀴틴에 융합된 HCV의 비구조 5-1.2 단백질에 관한 것이다.The present invention uses an expression vector that comprises a non-structural 5-1.2 protein gene of HCV in combination with a ubiquitin gene to produce a fusion protein of non-structural 5-1.2 protein and ubiquitin of HCV, and uses the expression vector. To a method for mass production of the nonstructural 5-1.2 protein of HCV and to the nonstructural 5-1.2 protein of HCV fused to the ubiquitin produced thereby.

Description

C형 간염 바이러스의 비구조 5-1.2 단백질의 제조방법Method for preparing non-structural 5-1.2 protein of hepatitis C virus

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

제1도는 C형 간염 바이러스의 비구조 5-1.2 유전자의 염기 서열 및 아미노산 서열을 나타낸 것이고,Figure 1 shows the nucleotide sequence and amino acid sequence of the nonstructural 5-1.2 gene of hepatitis C virus,

제2도는 C형 간염 바이러스의 비구조 5-1.2 유전자의 연결 전략 및 생성된 발현 벡터를 도시한 것이고,2 shows the strategy of linking the nonstructural 5-1.2 gene of the hepatitis C virus and the resulting expression vector,

제3도의 A는 비구조 5-1.2 유전자의 발현을 SDS 폴리아크릴아미드 젤 전기영동으로 확인한 결과를 나타낸 것이며,A of FIG. 3 shows the results of confirming the expression of the nonstructural 5-1.2 gene by SDS polyacrylamide gel electrophoresis.

제3도의 B는 비고조 5-1.2 유전자의 발현물을 C형 간염환자의 혈청으로 웨스턴 블롯팅한 결과를 나타낸 것이다.B of FIG. 3 shows the result of Western blotting the expression of the non-alcoholic 5-1.2 gene into the serum of hepatitis C patients.

Claims (8)

유비퀴틴에 하기 아미노산 서열을 갖는 한국형 C형 간염 바이러스의 비구조 5-1.2 단백질이 융합된 재조합 단백질.A recombinant protein in which ubiquitin is fused with a non-structural 5-1.2 protein of a Korean hepatitis C virus having the following amino acid sequence. 제1항의 재조합 단백질을 코딩하는 뉴클레오티드 서열을 갖는 DNA.DNA having a nucleotide sequence encoding the recombinant protein of claim 1. 제2항에 있어서, 한국형 C형 간염 바이러스의 비구조 5-1.2 단백질을 코딩하는 하기 뉴클레오티드 서열을 포함하는 DNA.The DNA of claim 2 comprising the following nucleotide sequence encoding the nonstructural 5-1.2 protein of the Korean hepatitis C virus. 제2항 또는 제3항의 DNA를 포함하는 발현벡터.An expression vector comprising the DNA of claim 2 or 3. 제4항에 있어서, ptrpH-UB-NS5-1.2인 발현벡터.The expression vector according to claim 4, which is ptrpH-UB-NS5-1.2. 제4항 또는 제5항의 발현벡터로 형질전환된 대장균.E. coli transformed with the expression vector of claim 4 or 5. 제6항에 있어서, ptrpH-UB-NS5-1.2로 형질전환된 대장균.The Escherichia coli transformed with ptrpH-UB-NS5-1.2. 제6항 또는 제7항의 대장균을 배양함을 포함하는, 유비퀴틴에 융합된 C형 간염 바이러스의 비구조 5-1.2 유전자 단백질의 제조방법.A method for producing a non-structural 5-1.2 gene protein of hepatitis C virus fused to ubiquitin, comprising culturing Escherichia coli according to claim 6 or 7. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019930004165A 1993-03-18 1993-03-18 Method for preparing non-structural 5-1.2 protein of hepatitis C virus KR940021733A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1019930004165A KR940021733A (en) 1993-03-18 1993-03-18 Method for preparing non-structural 5-1.2 protein of hepatitis C virus
KR1019930026611A KR100285585B1 (en) 1993-03-18 1993-12-06 Process for producing nonstructural 5-1.2 protein of hepatitis c virus(hcv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019930004165A KR940021733A (en) 1993-03-18 1993-03-18 Method for preparing non-structural 5-1.2 protein of hepatitis C virus

Publications (1)

Publication Number Publication Date
KR940021733A true KR940021733A (en) 1994-10-19

Family

ID=37514431

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1019930004165A KR940021733A (en) 1993-03-18 1993-03-18 Method for preparing non-structural 5-1.2 protein of hepatitis C virus
KR1019930026611A KR100285585B1 (en) 1993-03-18 1993-12-06 Process for producing nonstructural 5-1.2 protein of hepatitis c virus(hcv)

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1019930026611A KR100285585B1 (en) 1993-03-18 1993-12-06 Process for producing nonstructural 5-1.2 protein of hepatitis c virus(hcv)

Country Status (1)

Country Link
KR (2) KR940021733A (en)

Also Published As

Publication number Publication date
KR100285585B1 (en) 2001-04-02
KR940021575A (en) 1994-10-19

Similar Documents

Publication Publication Date Title
KR830007825A (en) Hybrid Human Leukocyte Interferon
ATE142700T1 (en) GENETIC MANIPULATIONS USING RECOMBINANT DNA CONTAINING SEQUENCES DERIVED FROM RNA VIRUSES
NO20015587D0 (en) Expression and export of interferon <alpha> proteins such as Fc fusion proteins
DK84194A (en) Recombinant hepatitis B virus DNA molecules, host organisms transformed therewith, HBV antigenetic polypeptides, DNA sequences encoding them, methods for detecting hepatitis B virus antibodies in blood serum, methods for producing said DNA molecules, methods for producing said polypeptides, detection agents
KR970707153A (en) Cathepsin 02 Protease (CATHEPSIN 02 PROTEASE)
DK0484787T3 (en) HCV-specific peptides, method of obtaining them and their use
KR870010196A (en) Pre-S Gene Coded Peptides, Hepatitis B Immunity, Wax, Diagnostics and Synthetic Liposomal Carriers
KR940021732A (en) Expression of the Nonstructural 4-Part Protein of Hepatitis C Virus
KR940021733A (en) Method for preparing non-structural 5-1.2 protein of hepatitis C virus
DE3853693D1 (en) TBE virus western subtype DNA and RNA molecules, polypeptides encoded by these molecules, and their use.
KR910016923A (en) Preparation of thrombin binding substance
DK0691404T3 (en) Vaccine for immunization against TBE virus infections as well as a method for their preparation
DK0475182T3 (en) Method for protein synthesis using CKS fusion proteins
KR970006317A (en) Fusion protein of HCV core protein and preparation method thereof
KR970059276A (en) Method for producing the vacuolar cytotoxin protein of Helicobacter pylori from recombinant E. coli
KR970010787A (en) Fusion protein comprising hepatitis B virus surface antigen and hepatitis C virus envelope protein and mixed vaccine comprising the same
KR900009979A (en) Japanese encephalitis virus non-structural protein production method
KR950005989A (en) Expression of human interleukin-3 in yeast
KR950005993A (en) Baculovirus expression vector of the 2 (E2) protein gene of hepatitis C virus and method for producing the 2 (E2) protein using the same
KR950005840A (en) 2B protease of hepatitis C virus and preparation method thereof
KR950005990A (en) Expression of human interleukin-4 in yeast
KR960037837A (en) Method for preparing non- (B) hepatitis virus surface antigen pre-S1
ATE547427T1 (en) METHOD FOR THE RECOMBINANT PRODUCTION OF RIBONUCLEOPROTEINS
DE602004024314D1 (en) COEXPRESSION VECTOR FOR THE MEMBRANEOMANS OF VIRUS SHELL PROTEINS AND USES THEREOF
KR950025096A (en) Mass production method of novel heat resistant Topi DNA polymerase